Biochemical Profile Affects IOPTH Kinetics and Cure Rate in Primary Hyperparathyroidism

  • Claire E. Graves
  • Catherine M. McManus
  • John A. Chabot
  • James A. Lee
  • Jennifer H. KuoEmail author
Original Scientific Report



Recently, normocalcemic (NC) and normohormonal (NH) variants of primary hyperparathyroidism (pHPT) have been described, with distinct biochemical profiles from the typical high serum calcium and parathyroid hormone (PTH) levels. Here, we investigate whether biochemical profile affects cure rate, as well as the kinetics of intraoperative PTH (IOPTH).


This is a single-center, retrospective study of pHPT patients undergoing parathyroidectomy. Patients were grouped based on preoperative calcium and PTH levels into typical, NC (normal calcium, elevated PTH, no evidence of secondary hyperparathyroidism), and NH (elevated calcium, unsuppressed PTH) biochemical profiles. All patients had IOPTH monitoring and ≥6-month post-op serum studies to confirm surgical cure. Patient variables were analyzed with Kruskal–Wallis test and Chi-square analysis. IOPTH kinetic curves were analyzed using a linear mixed model.


From June 2006 to October 2014, 646 patients met inclusion criteria. Biochemical profile was typical in 460 patients (71%), NC in 101 (16%), and NH in 85 (13%). IOPTH levels were higher at all time points in typical patients, p < 0.001. Surgical cure rates were significantly lower for NC patients (90.1%) than for typical (98.5%) or NH patients (97.7%), p < 0.001, although a stricter criteria for cure was used in this group (normal calcium AND normal PTH). In a multivariable linear mixed model, NC patients had a significantly slower rate of IOPTH decline (p < 0.001 at 10 min).


Here, we better characterize the atypical variants of pHPT. Using a stricter definition of cure in the NC variant, these patients have a lower surgical cure rate than typical or NH variants in pHPT. The IOPTH curve is affected by biochemical profile, with both NC and NH patients having lower absolute values and NC patients having a slower decline.


Authors’ contributions

CG contributed to data acquisition, analysis and interpretation of data, and drafting of the manuscript; CM contributed to acquisition of data and critical revisions; JC and JL performed critical revisions; JK contributed to study conception and design, analysis and interpretation of data, and drafting of the manuscript.

Compliance with ethical standards

Conflicts of interest

The authors declare they have no proprietary or commercial interest in any product mentioned or concept discussed in this article.


  1. 1.
    Bandeira L, Bilezikian J (2016) Primary hyperparathyroidism. F1000Res 5Google Scholar
  2. 2.
    Wilhelm SM, Wang TS, Ruan DT et al (2016) The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959–968CrossRefGoogle Scholar
  3. 3.
    Bilezikian JP, Cusano NE, Khan AA et al (2016) Primary hyperparathyroidism Nat Rev Dis Primers 2:16033CrossRefGoogle Scholar
  4. 4.
    Pasieka JL, Parsons L, Jones J (2009) The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery 146:1006–1013CrossRefGoogle Scholar
  5. 5.
    Silverberg SJ, Clarke BL, Peacock M et al (2014) Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99:3580–3594CrossRefGoogle Scholar
  6. 6.
    Tassone F, Guarnieri A, Castellano E et al (2015) Parathyroidectomy Halts the deterioration of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab 100:3069–3073CrossRefGoogle Scholar
  7. 7.
    Lundstam K, Heck A, Godang K et al (2017) Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study). J Bone Miner Res 32:1907–1914CrossRefGoogle Scholar
  8. 8.
    Rao DS, Phillips ER, Divine GW et al (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422CrossRefGoogle Scholar
  9. 9.
    Sheldon DG, Lee FT, Neil NJ, et al. (2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137:1022–1026 (discussion 1026–1028).CrossRefGoogle Scholar
  10. 10.
    Cheng SP, Lee JJ, Liu TP et al (2015) Quality of Life after surgery or surveillance for asymptomatic primary hyperparathyroidism: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 94:e931CrossRefGoogle Scholar
  11. 11.
    Mather HG (1953) Hyperparathyroidism with normal serum calcium. Br Med J 2:424–425CrossRefGoogle Scholar
  12. 12.
    Wills MR, Pak CY, Hammond WG et al (1969) Normocalcemic primary hyperparathyroidism. Am J Med 47:384–391CrossRefGoogle Scholar
  13. 13.
    Siperstein AE, Shen W, Chan AK, et al. (1992) Normocalcemic hyperparathyroidism. Biochemical and symptom profiles before and after surgery. Arch Surg 127:1156–1157 (discussion 1161–1153).CrossRefGoogle Scholar
  14. 14.
    Lavryk OA, Siperstein AE (2017) Use of calcium and parathyroid hormone nomogram to distinguish between atypical primary hyperparathyroidism and normal patients. World J Surg 41:122–128CrossRefGoogle Scholar
  15. 15.
    Applewhite MK, White MG, Tseng J et al (2017) Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism. Surgery 161:62–69CrossRefGoogle Scholar
  16. 16.
    Lim JY, Herman MC, Bubis L et al (2017) Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism. Surgery 161:70–77CrossRefGoogle Scholar
  17. 17.
    Trinh G, Noureldine SI, Russell JO et al (2017) Characterizing the operative findings and utility of intraoperative parathyroid hormone (IOPTH) monitoring in patients with normal baseline IOPTH and normohormonal primary hyperparathyroidism. Surgery 161:78–86CrossRefGoogle Scholar
  18. 18.
    Trinh G, Rettig E, Noureldine SI et al (2018) Surgical management of normocalcemic primary hyperparathyroidism and the impact of intraoperative parathyroid hormone testing on outcome. Otolaryngol Head Neck Surg 159:630–637CrossRefGoogle Scholar
  19. 19.
    Lee D, Walker MD, Chen HY et al (2019) Bone mineral density changes after parathyroidectomy are dependent on biochemical profile. Surgery 165:107–113CrossRefGoogle Scholar
  20. 20.
    Udelsman R, Akerstrom G, Biagini C et al (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99:3595–3606CrossRefGoogle Scholar
  21. 21.
    Greene AB, Butler RS, McIntyre S et al (2009) National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg 209:332–343CrossRefGoogle Scholar
  22. 22.
    Carneiro DM, Solorzano CC, Nader MC, et al. (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 134:973–979 (discussion 979–981).CrossRefGoogle Scholar
  23. 23.
    Irvin GL 3rd, Solorzano CC, Carneiro DM (2004) Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 28:1287–1292. CrossRefGoogle Scholar
  24. 24.
    Sokoll LJ, Drew H, Udelsman R (2000) Intraoperative parathyroid hormone analysis: A study of 200 consecutive cases. Clin Chem 46:1662–1668Google Scholar
  25. 25.
    Venkat R, Kouniavsky G, Tufano RP et al (2012) Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg 36:55–60CrossRefGoogle Scholar
  26. 26.
    Richards ML, Thompson GB, Farley DR et al (2011) An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg 146:280–285CrossRefGoogle Scholar
  27. 27.
    Sho S, Kuo EJ, Chen AC et al (2019) Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism. Ann Surg Oncol 26:539–546CrossRefGoogle Scholar
  28. 28.
    Wade TJ, Yen TW, Amin AL et al (2012) Surgical management of normocalcemic primary hyperparathyroidism. World J Surg 36:761–766CrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2019

Authors and Affiliations

  • Claire E. Graves
    • 1
  • Catherine M. McManus
    • 1
  • John A. Chabot
    • 1
  • James A. Lee
    • 1
  • Jennifer H. Kuo
    • 1
    Email author
  1. 1.Department of SurgeryColumbia University Medical CenterNew YorkUSA

Personalised recommendations